Sodium Iodide [131i] Ge Healthcare

Sodium Iodide [131I] from GE Healthcare is a radioactive iodine solution used for diagnostic and therapeutic thyroid procedures. This radiopharmaceutical emits beta and gamma radiation for precise imaging and treatment. Short-term storage at controlled temperatures is recommended for stability.

Sodium Iodide [131I] is commonly used in medical imaging and treatment of thyroid conditions. It helps diagnose thyroid disorders by evaluating iodine uptake and is also used in thyroid cancer therapy. This radiopharmaceutical is administered orally and works by targeting thyroid tissue.

After administration, Sodium Iodide [131I] is absorbed by the thyroid gland, where it emits radiation to aid in imaging or treatment. Patients may experience mild effects such as a metallic taste or temporary thyroid gland sensitivity. The effects are localized to the thyroid region.

Sodium Iodide [131I] should be handled with care due to its radioactive properties. Pregnant or breastfeeding individuals should avoid exposure. Patients must follow healthcare provider instructions for preparation and post-administration safety measures.

Certain medications, such as thyroid hormones or iodine-containing supplements, may interfere with Sodium Iodide [131I] uptake. Patients should inform healthcare providers about all medications and supplements before administration. Alcohol and specific foods may also affect iodine absorption.